AMRI Announces Second Quarter 2016 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Albany Molecular Research (AMRI) Tops Q2 EPS by 4c; Updates FY16 Expectations
August 4, 2016 7:34 AM EDTAlbany Molecular Research (NASDAQ: AMRI) reported Q2 EPS of $0.36, $0.04 better than the analyst estimate of $0.32. Revenue for the quarter came in at $116.5 million versus the consensus estimate of $123.1 million.
GUIDANCE:
Albany Molecular Research sees FY2016 EPS of $1.03-$1.11, versus the... More
